| Dr Vijaya Subbu Natchimuthu, MD | |
|
303 E Overton Rd, Dallas, TX 75216 | |
| (214) 266-4000 | |
| Not Available |
| Full Name | Dr Vijaya Subbu Natchimuthu |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 303 E Overton Rd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124388939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4301100345 (Michigan) | Secondary |
| 207Q00000X | Family Medicine | Q5508 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkland Health & Hospital System | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dallas County Hospital District | 8325934813 | 448 |
News Archive
Today's headlines include a report about a new poll showing public uneasiness is increasing in regard to the health law. At the same time, the White House is stepping up its efforts encourage people to enroll in the health coverage the will be available as a result of the overhaul.
The results from a new study published in The Lancet demonstrate that high- quality measles immunization campaigns and improvements in routine immunization services have reduced measles cases by 91% in 19 African nations from 2000-2003, preventing an estimated 90,000 child deaths in 2003 alone.
Transition Therapeutics Inc. announced today that a clinical study of gastrin analogue TT-223 in combination with a Lilly proprietary GLP-1 analogue in patients with type 2 diabetes did not meet its efficacy endpoints. Given these findings, there will be no further development of TT-223.
KE Eye Centers of Texas is the first in the Dallas-Fort Worth Metroplex to provide a new solution for patients with moderate to high levels of myopia and astigmatism in one simple procedure, following FDA approval of STAAR Surgical's Visian Toric ICL.
› Verified 9 days ago
| Entity Name | Dallas County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831198506 PECOS PAC ID: 8325934813 Enrollment ID: O20040315000583 |
News Archive
Today's headlines include a report about a new poll showing public uneasiness is increasing in regard to the health law. At the same time, the White House is stepping up its efforts encourage people to enroll in the health coverage the will be available as a result of the overhaul.
The results from a new study published in The Lancet demonstrate that high- quality measles immunization campaigns and improvements in routine immunization services have reduced measles cases by 91% in 19 African nations from 2000-2003, preventing an estimated 90,000 child deaths in 2003 alone.
Transition Therapeutics Inc. announced today that a clinical study of gastrin analogue TT-223 in combination with a Lilly proprietary GLP-1 analogue in patients with type 2 diabetes did not meet its efficacy endpoints. Given these findings, there will be no further development of TT-223.
KE Eye Centers of Texas is the first in the Dallas-Fort Worth Metroplex to provide a new solution for patients with moderate to high levels of myopia and astigmatism in one simple procedure, following FDA approval of STAAR Surgical's Visian Toric ICL.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vijaya Subbu Natchimuthu, MD Po Box 660599, Dallas, TX 75266-0599 Ph: () - | Dr Vijaya Subbu Natchimuthu, MD 303 E Overton Rd, Dallas, TX 75216 Ph: (214) 266-4000 |
News Archive
Today's headlines include a report about a new poll showing public uneasiness is increasing in regard to the health law. At the same time, the White House is stepping up its efforts encourage people to enroll in the health coverage the will be available as a result of the overhaul.
The results from a new study published in The Lancet demonstrate that high- quality measles immunization campaigns and improvements in routine immunization services have reduced measles cases by 91% in 19 African nations from 2000-2003, preventing an estimated 90,000 child deaths in 2003 alone.
Transition Therapeutics Inc. announced today that a clinical study of gastrin analogue TT-223 in combination with a Lilly proprietary GLP-1 analogue in patients with type 2 diabetes did not meet its efficacy endpoints. Given these findings, there will be no further development of TT-223.
KE Eye Centers of Texas is the first in the Dallas-Fort Worth Metroplex to provide a new solution for patients with moderate to high levels of myopia and astigmatism in one simple procedure, following FDA approval of STAAR Surgical's Visian Toric ICL.
› Verified 9 days ago
Dr. Juan F Quiroz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4811a Columbia Ave, Dallas, TX 75226 Phone: 214-823-5590 Fax: 214-823-6638 | |
Dr. Michelle Dobbs, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 6333 E Mockingbird Ln, Suite 126, Dallas, TX 75214 Phone: 214-826-6005 | |
Howard J Huntzinger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9250 Amberton Pkwy, Dallas, TX 75243 Phone: 682-236-3656 | |
Robert J Dimeff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8081 Walnut Hill Ln, Dallas, TX 75231 Phone: 214-750-1207 Fax: 214-739-5029 | |
Pardeep K Shori, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7012 La Vista Dr, Dallas, TX 75214 Phone: 817-564-5761 | |
Mary Elizabeth Wilcox Smith, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2921 Fairmount St, Dallas, TX 75201 Phone: 214-742-9310 | |
Elizabeth Chapek, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 6760 Abrams Rd, Suite 203, Dallas, TX 75231 Phone: 214-341-8742 |